Case Report: Long-term survival with erlotinib for lung cancer with secondary leptomeningeal carcinomatosis - Quiz - MDSpire

Case Report: Long-term survival with erlotinib for lung cancer with secondary leptomeningeal carcinomatosis

  • By

  • Diego Neira

  • Paloma Ruiz

  • Barbara Nuñez

  • Gonzalo Navarrete

  • Rodrigo Vasquez

  • Luis Villanueva

  • Olga Barajas

  • May 14, 2026

  • 0 min

Share

Original Source(s)

Case Report: Long-term survival with erlotinib for lung cancer with secondary leptomeningeal carcinomatosis

  • by Diego Neira, Paloma Ruiz, Barbara Nuñez, Gonzalo Navarrete, Rodrigo Vasquez, Luis Villanueva, Olga Barajas

  • May 14, 2026

Related Content

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer

Tumor irradiation promotes antigen dressing of dendritic cells to enhance CAR T cell persistence and efficacy in lung metastases

Dosimetric and clinical outcomes of stereotactic body radiotherapy for primary lung cancer: isocenter-based vs. volume-based prescription